The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government ...

After the virologic failure of cabotegravir/rilpivirine and despite dual-class resistance mutations, Canadian doctors have ...

HEALTH and Child Care minister Douglas Mombeshora has reaffirmed the country’s commitment to advancing HIV research, treatment and global collaboration. He said this during the ongoing 13th ...

Researchers wanted to provide insight into the relative clinical value of Apretude and lenacapavir compared with no ...

Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...

"PEPFAR funding protection offers “hope” for people living with HIV" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

An investigational once-weekly oral antiretroviral therapy (ART) combination effectively maintained viral suppression in ...

Let us refresh the old gold Buddhist tale of The Quail and the Net: ldquo;Long ago a flock of quails lived in a forest .

The U.S. Senate has opened debate on a $9 billion rescission bill to claw back foreign aid and other funding not aligned with ...

A decade ago, the global community established the goal to end AIDS as a public health threat by 2030 through reducing new HIV infections and AIDS-related deaths by 90% from 2010 levels.1 Progress has ...

The temporary suspension of PEPFAR has disrupted preventive treatments, infant testing, and the work of community health ...

The World Health Organization has suggested global release of lenacapavir, a twice-yearly injectable medication, as a powerful HIV infection-fighting medication. The historic suggestion was made ...